ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,454Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 682

$1.35M Total Retail Price of All Prescriptions

Rank: 52 out of 682

634 Patients Receiving at Least One Drug in Part D
91% Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Kentucky
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

11% of this provider’s 634 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 634 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
FUROSEMIDE 1,221 1,191 140 1 7
AMLODIPINE BESYLATE 1,177 1,129 116 2 4
LEVOTHYROXINE SODIUM 1,113 1,042 106 3 2
LISINOPRIL 801 766 137 4 3
NAMENDA 794 768 61 5 29
SIMVASTATIN 685 636 123 6 6
SERTRALINE HCL 556 534 63 7 25
POTASSIUM CHLORIDE 492 456 60 8 14
OMEPRAZOLE 460 430 98 9 5
HYDROCODONE-ACETAMINOPHEN 449 399 85 S3 10 1
ATORVASTATIN CALCIUM 447 420 58 11 8
DONEPEZIL HCL 440 429 60 12 33
METFORMIN HCL 410 346 69 13 10
NOVOFINE AUTOCOVER 398 381 47 10 14 230
METOPROLOL TARTRATE 382 377* 76 15 11
POLYETHYLENE GLYCOL 3350 369 355 84 16 48
LORAZEPAM 363 335 73 B 17 34
CITALOPRAM HBR 350 322 50 18 20
WARFARIN SODIUM 334 287 48 19 15
PANTOPRAZOLE SODIUM 318 286 55 20 23
GABAPENTIN 305 267 44 21 9
LANTUS SOLOSTAR 285 272 44 22 92
MIRTAZAPINE 280 268 45 23 51
RANITIDINE HCL 278 273* 45 24 30
XARELTO 274 263 22 25 149
CLOPIDOGREL 254 235 42 26 16
ZOLPIDEM TARTRATE 249 244* 31 27 28
NYSTATIN 238 233* 49 28 83
FLUTICASONE PROPIONATE 236 225 77 29 38
CARVEDILOL 232 227* 39 30 24
NOVOLOG FLEXPEN 220 215* 39 31 184
METOPROLOL SUCCINATE 215 196 37 32 17
CLOTRIMAZOLE-BETAMETHASONE 213 208* 39 33 226
PRAVASTATIN SODIUM 213 195 40 33 13
BUSPIRONE HCL 207 202* 32 35 87
ALLOPURINOL 206 206 23 36 35
ISOSORBIDE MONONITRATE ER 205 200* 26 37 40
LOSARTAN POTASSIUM 201 196* 31 38 19
KLOR-CON 10 197 197 20 39 147
CYMBALTA 191 186* 17 40 45
QUETIAPINE FUMARATE 188 183* 24 A 41 71
HYDROCHLOROTHIAZIDE 182 164 41 42 12
KLOR-CON M20 180 175* 40 43 74
TRAZODONE HCL 179 156 28 44 41
PREDNISONE 178 167 61 45 42
LACTULOSE 174 169* 47 46 100
LEVETIRACETAM 172 105 19 47 108
TRIAMCINOLONE ACETONIDE 171 166* 29 48 139
HYDRALAZINE HCL 168 163* 26 49 76
ALENDRONATE SODIUM 159 154* 31 50 49
MONTELUKAST SODIUM 155 144 32 51 31
CRESTOR 151 115 17 52 26
LEVEMIR FLEXPEN 151 136 19 52 164
RISPERIDONE 149 144* 27 A 54 89
ALPRAZOLAM 146 113 26 B 55 18
CARBIDOPA-LEVODOPA 146 141* 22 55 136
ESCITALOPRAM OXALATE 143 138* 23 57 46
LOVASTATIN 140 135* 19 58 75
DIOVAN 138 138 17 59 50
PAROXETINE HCL 137 119 20 60 58
JANUVIA 137 120 15 60 54
DIVALPROEX SODIUM 131 119 21 62 86
NEXIUM 129 124* 17 63 22
ATENOLOL 127 104 24 64 21
SPIRIVA 126 121* 22 65 57
MELOXICAM 124 119* 27 66 27
TAMSULOSIN HCL 120 120 23 67 37
BYSTOLIC 118 113* 15 68 101
OXYCONTIN 115 <11 <11 S2 69 182
IPRATROPIUM-ALBUTEROL 106 95 49 70 120
SYMBICORT 105 100* 26 71 109
CLONIDINE HCL 105 93 26 71 56
SPIRONOLACTONE 104 99* 20 73 65
HUMALOG 99 99 14 74 172
AMIODARONE HCL 97 85 18 75 167
NAMENDA XR 96 96 16 76 325
OXYCODONE-ACETAMINOPHEN 95 90* 21 S2 77 111
VENLAFAXINE HCL ER 89 84* 11 78 105
KLOR-CON M10 89 84* 27 78 176
TORSEMIDE 84 <11 <11 80 150
LIDODERM 83 78* 17 81 160
OXYCODONE HCL 83 78* 14 S2 81 88
CIPROFLOXACIN HCL 81 76* 67 83 67
LATANOPROST 77 77 14 84 258
LABETALOL HCL 74 59 11 85 252
BETAMETHASONE VALERATE 73 <11 <11 86 415
PROCTOZONE-HC 72 72 22 87 416
DILTIAZEM 24HR CD 72 72 15 87 130
AMITRIPTYLINE HCL 68 48 15 R 89 60
DIGOXIN 66 66 14 90 153
FAMOTIDINE* 66 61* 12 90 93
LOPERAMIDE 66 61* 26 90 250
DETROL LA 66 <11 <11 90 218
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 59* 46 94 107
ROPINIROLE HCL 64 <11 <11 94 73
KETOCONAZOLE 62 62 19 96 316
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 56* 12 97 39
BACLOFEN 61 30 12 97 117
METOLAZONE 61 56* 16 97 213
FENTANYL 61 56* 15 S2 97 95
PROMETHAZINE HCL 60 55* 32 R 101 80
LEVOCETIRIZINE DIHYDROCHLORIDE 60 <11 <11 101 169
MEGESTROL ACETATE 58 58 15 R 103 191
ISOSORBIDE MONONITRATE 56 <11 <11 104 299
LEVOFLOXACIN 56 51* 43 104 59
AZITHROMYCIN 55 50* 47 106 55
TEMAZEPAM 54 <11 <11 B 107 90
AMOX TR-POTASSIUM CLAVULANATE 54 49* 47 107 112
TRAMADOL HCL 54 26 12 107 32
NYSTATIN-TRIAMCINOLONE 54 <11 <11 107 448
CELEBREX 54 <11 <11 107 82
RANEXA 53 <11 <11 112 187
VANCOMYCIN HCL* 53 48* 13 112 289
EXELON 52 <11 <11 114 134
HYDROXYZINE HCL 51 51 15 R 115 197
AZELASTINE HCL 50 50 14 116 324
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.